skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

The number of high-risk class I recalls ballooned 88% in the second quarter of 2017. Overall, recalls fell 3%. Check out our Q2 recalls infographic.





There was a dramatic increase in the number of high-risk class I medical device recalls in the second quarter of 2017. There were 15 class I recall events logged with US FDA from April through June, up 88% from the first quarter of the year, when only eight were posted, according to consulting firm Stericycle, which gathered its recalls data from FDA Enforcement Reports. Overall, recalls fell 3% in Q2 '17, to 275 (compared to Q1's 284). Meanwhile, the number of recalled device units increased by a massive 628%, climbing to nearly 67.6 million units in Q2 '17, from 9.2 million in Q1. For a snapshot of Q2 results, see the infographic of Stericycle data below.



Q2 Recalls Snapshot



Read also


Next steps

Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: